Scotia Capital’s Legence LGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.14M Buy
39,951
+1,241
+3% +$76.9K 0.01% 476
2026
Q2
$3.3M Sell
38,710
-977
-2% -$79.6K 0.01% 390
2026
Q1
$2.24M Sell
39,687
-96
-0.2% -$4.84K 0.01% 435
2025
Q4
$1.71M Buy
+39,783
New +$1.57M 0.01% 482

Other funds holding LGN

Scotia Capital's LGN Position: Q3 2026 in Review

Scotia Capital increased its Legence (LGN) stake by 3.2% in Q3 2026, buying an estimated $76.9K and bringing the position to 39,951 shares worth $2.14M. The position accounts for 0.01% of the portfolio, ranked #476.

Scotia Capital first reported a position in LGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.3M in Q2 2026. 262 funds tracked by Wall St. Rank hold LGN as of Q3 2026.

  • Scotia Capital held 39,951 shares of Legence worth $2.14M as of Q3 2026.
  • Scotia Capital bought 1,241 Legence shares in Q3 2026, an estimated $76.9K.
  • Legence made up 0.01% of Scotia Capital's portfolio in Q3 2026, its #476 holding.
  • Scotia Capital first reported a position in Legence in Q4 2025 and has held it in 4 quarters since.
  • Scotia Capital's Legence position peaked at $3.3M in Q2 2026.
  • 262 funds tracked by Wall St. Rank held Legence as of Q3 2026.

Based on Scotia Capital's 13F filing for Q3 2026, filed 10 Nov 2026.